Delivery Order SPE2DB20D3103-SPE2DB25FQ0B3
Award Date 8/25/25
Potential Completion Date 9/16/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $9,670.51 and is scheduled for completion by August 26, 2025. The contract is not subject to any small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30 units. This contract is valued at $8,552.49 with a firm fixed price structure and represents a non-set-aside, competitively awarded procurement. The delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,403.32 to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets (30-count units). The contract, awarded July 21, 2025, carries a firm fixed price and is scheduled for completion by August 11, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global...
- The Defense Logistics Agency awarded a $8.55K delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside competitive award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the breadth of pharmaceutical products procured...
- The Defense Logistics Agency awarded a delivery order valued at $16,588.64 to AmerisourceBergen Drug Corp for supply of Mekinist 2 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy used in melanoma and other oncological treatments, reflecting the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mekinist (trametinib) 2 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract has a ceiling value of $19,341.02 and firm fixed pricing, with ultimate completion scheduled for September 2, 2025. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,341.02, is for the supply of Mekinist 2 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order with a period of performance through February 27, 2025. It was awarded on February 5, 2025 and does not have a set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mekinist 0.05 mg/ml solution (90 ml) under a firm fixed-price contract valued at $5,576.15, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mekinist 2 mg tablets. The $8,878.79 firm-fixed price contract has an ultimate completion date of October 28, 2024. It does not have a set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Mekinist 2 mg Tablet, with a total ceiling value of $9,670.51 and a period of performance through July 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...